Her sentiment on the market cap and the share price is similar...

Her sentiment on the market cap and the share price is similar to your's Grantjo.... indeed probably worse than yours. At that level she is impatient .... which is good for the stock.

5 year down the track on CDY the risk factor was always the clock rather than the science or the wide applicability of the science. The clock still ticks away BUT todays news on top of the other parrallel global patients provides a futher 20 years of royalty benefit to key areas of the IP.

I am now expecting news on 1) a therapeutic collaboration 2) diagnostic royalties and 3) OTC developments. I have no ideas as to the order or timing of any of it .... except to say soon.

cheers